Avalo Therapeutics, Inc. 4 filing

Filed 2026-05-19 · Report date 2026-05-15 · 2026

View Original SEC Filing

Filing metadata

Accession number: 0001918845-26-000012
Form type: 4
CIK: 0001534120
Primary document: https://www.sec.gov/Archives/edgar/data/1534120/000191884526000012/xslF345X06/form4-05192026_040503.xml

Extracted primary information

This filing includes deterministic financial metrics extracted from public filing data for Avalo Therapeutics, Inc..

Reported financial metrics

Metric	Current	Prior	Change